Sickle Cell Anemia Screening and Prevention in Northern Israel

HaEmek Medical Center, Israel

Status: Completed

Conditions: Thalassemia; Sickle Cell Anemia

Treatments: Other: Observational

Study type: Observational

Funder types: Other

Identifiers

NCT00735488

0011-08-EMC

Details and patient eligibility

About

Since 1987, a screening for β Thalassemia in pregnant women is carried on in northern Israel, and from 1999 all the samples were tested also for Hgb S, Hgb C, Hgb D, Hgb O Arab and others.

In this study, the investigators intend to summarize the results of this preventive program aiming to detect couples at risk for having offspring with Thalassemia or SCA, the compliance regard to genetic counseling and prenatal diagnosis and the incidence of new affected babies born.

Enrollment: 69 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: All pregnant women tested and their husband in those cases that the woman test revealed abnormal hemoglobin.

Exclusion Criteria: No exclusion criteria.

Trial design

69 participants in 2 patient groups

A

Description:

Thalassemia Minor carriers

Treatment:

Other: Observational

B

Description:

Sickle cell carriers

Treatment:

Other: Observational